Therapeutic targets for cardiac fibrosis: from old school to next-gen is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0. It has been cited 175 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01HL150225-03
Small molecule therapies targeting chromatin architecture in heart failure
National Institutes of Health
Grant: 1R01HL127240-01
Regulation of Chromatin Signaling in Heart Failure by BET Bromodomain Proteins
National Institutes of Health
Grant: 5R01DK119594-03
Screening and Development of Small Molecule HDAC11 Inhibitors to Treat Obesity and Diabetes.
National Institutes of Health
Grant: 5R01HL147558-02
Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEF
National Institutes of Health
Grant: 1R43HL154959-01
Targeting HDAC6 to Modulate Titin Stiffness for Dilated Cardiomyopathy Therapy
National Institutes of Health
Grant: 5F32HL147463-02
Exploring the Therapeutic Potential of BRD4 Extra-terminal Domain Inhibition in Cardiac Dysfunction and Remodeling. Fellow: Joshua Travers
National Institutes of Health
Grant: 2R01HL116848-05A1
Regulation of Cardiac Signaling by Class I Histone Deacetylases
NHLBI NIH HHS
Grant: R43 HL154959
NHLBI NIH HHS
Grant: R01 HL116848
NHLBI NIH HHS
Grant: R01 HL127240
NHLBI NIH HHS
Grant: R01 HL147558
NHLBI NIH HHS
Grant: R01 HL150225
NIDDK NIH HHS
Grant: R01 DK119594
NHLBI NIH HHS
Grant: T32 HL007822
NHLBI NIH HHS
Grant: F32 HL147463
FWCI
24.28
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals